These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 8974687
21. Discarded cellular components and the technical efficiency of component preparation. Veihola M, Aroviita P, Kekomäki R, Linna M, Sintonen H. Eur J Health Econ; 2008 Nov; 9(4):325-31. PubMed ID: 17962987 [Abstract] [Full Text] [Related]
22. [Storage-induced rheologic and biochemical changes in erythrocyte concentrates with added solution and possible correlations]. Mansouri Taleghani B, Grossmann R, Waltenberger G, Geise W, Langer R, Henrich HA, Wiebecke D. Beitr Infusionsther Transfusionsmed; 1996 Nov; 33():141-4. PubMed ID: 8974686 [Abstract] [Full Text] [Related]
23. Evaluation of a concurrent multicomponent collection system for the collection and storage of WBC-reduced RBC apheresis concentrates. Moog R, Franck V, Pierce JA, Müller N. Transfusion; 2001 Sep; 41(9):1159-64. PubMed ID: 11552075 [Abstract] [Full Text] [Related]
24. Markers of platelet activation and apoptosis in platelet concentrates collected by apheresis. Procházková R, Andrýs C, Hubácková L, Krejsek J. Transfus Apher Sci; 2007 Oct; 37(2):115-23. PubMed ID: 17945536 [Abstract] [Full Text] [Related]
25. [Current methods in blood preservation: recovery of blood components using a multi-bag system]. Bergmann H, Blauhut B, Gassner W, Haider M. Wien Med Wochenschr; 1991 Oct; 141(21):485-92. PubMed ID: 1781176 [Abstract] [Full Text] [Related]
26. Extended storage of AS-1 and AS-3 leukoreduced red blood cells for 15 days after deglycerolization and resuspension in AS-3 using an automated closed system. Bandarenko N, Hay SN, Holmberg J, Whitley P, Taylor HL, Moroff G, Rose L, Kowalsky R, Brumit M, Rose M, Sawyer S, Johnson A, McNeil D, Popovsky MA. Transfusion; 2004 Nov; 44(11):1656-62. PubMed ID: 15504173 [Abstract] [Full Text] [Related]
28. Segments from red blood cell units should not be used for quality testing. Kurach JD, Hansen AL, Turner TR, Jenkins C, Acker JP. Transfusion; 2014 Feb; 54(2):451-5. PubMed ID: 23834158 [Abstract] [Full Text] [Related]
29. A quality monitoring program for red blood cell components: in vitro quality indicators before and after implementation of semiautomated processing. Acker JP, Hansen AL, Kurach JD, Turner TR, Croteau I, Jenkins C. Transfusion; 2014 Oct; 54(10):2534-43. PubMed ID: 24805193 [Abstract] [Full Text] [Related]
30. Red blood cell depletion with a semiautomated system or hydroxyethyl starch sedimentation for routine cord blood banking: a comparative study. Solves P, Mirabet V, Planelles D, Blasco I, Perales A, Carbonell-Uberos F, Soler MA, Roig R. Transfusion; 2005 Jun; 45(6):867-73. PubMed ID: 15934983 [Abstract] [Full Text] [Related]
31. Clinical effects of different types of red cell concentrates in patients with thalassemia and sickle cell disease. Cabibbo S, Fidone C, Antolino A, Manenti OG, Garozzo G, Travali S, Bennardello F, Di Stefano R, Bonomo P. Transfus Clin Biol; 2007 Dec; 14(6):542-50. PubMed ID: 18434227 [Abstract] [Full Text] [Related]
32. Characterization of blood components prepared from whole-blood donations after a 24-hour hold with the platelet-rich plasma method. Thibault L, Beauséjour A, de Grandmont MJ, Lemieux R, Leblanc JF. Transfusion; 2006 Aug; 46(8):1292-9. PubMed ID: 16934062 [Abstract] [Full Text] [Related]
33. Successful in vivo recovery and extended storage of additive solution (AS)-5 red blood cells after deglycerolization and resuspension in AS-3 for 15 days with an automated closed system. Bandarenko N, Cancelas J, Snyder EL, Hay SN, Rugg N, Corda T, Joines AD, Gormas JF, Pratt GP, Kowalsky R, Rose M, Rose L, Foley J, Popovsky MA. Transfusion; 2007 Apr; 47(4):680-6. PubMed ID: 17381627 [Abstract] [Full Text] [Related]
34. The future of automated red blood cell collection. Smith JW, Gilcher RO. Transfus Apher Sci; 2006 Apr; 34(2):219-26. PubMed ID: 16513424 [Abstract] [Full Text] [Related]
35. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production. Levin E, Culibrk B, Gyöngyössy-Issa MI, Weiss S, Scammell K, LeFresne W, Jenkins C, Devine DV. Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169 [Abstract] [Full Text] [Related]
36. [Blood component therapy with additives]. Akerblom O. Beitr Infusionsther; 1990 Nov; 26():46-9. PubMed ID: 1703898 [Abstract] [Full Text] [Related]
37. Automation of the glycerolization of red blood cells with the high-separation bowl in the Haemonetics ACP 215 instrument. Valeri CR, Ragno G, Van Houten P, Rose L, Rose M, Egozy Y, Popovsky MA. Transfusion; 2005 Oct; 45(10):1621-7. PubMed ID: 16181213 [Abstract] [Full Text] [Related]
38. [Filtration of buffy coat-free erythrocyte suspensions in additive solution]. Dietrich K, Dietrich G, Kretschmer V, Eckle R, Heins M. Beitr Infusionsther; 1992 Oct; 30():162-5. PubMed ID: 1284696 [Abstract] [Full Text] [Related]
39. Red cell apheresis: new concepts of blood component processing. Matthes GA. Ther Apher; 1997 Feb; 1(1):22-8. PubMed ID: 10225776 [Abstract] [Full Text] [Related]
40. [Effect of whole blood preparation and leukocyte filtration on storage of erythrocyte concentrates over 42 days]. Müller-Steinhardt M, Janetzko K, Kirchner H, Klüter H. Beitr Infusionsther Transfusionsmed; 1997 Feb; 34():53-7. PubMed ID: 9417353 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]